Program

HOPE

Helps HOPE for advance drug testing and improve renal disease outcomes.

Wellcome LeapCooperative agreement

About

HOPE, short for Human Organs, Physiology, and Engineering, is a $50M Wellcome Leap program aimed at building human tissues, organoids, and organs. It sits under Wellcome Leap and is already active, with Annie Moisan, PhD, directing the work from an engineering and stem-cell science background. The program brings academic institutions, foundations, and companies into the same development effort.

I…

Industries covered

BiotechMedtechSynthetic Biology

Grants under HOPE

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

HOPE — Execution

Closed

Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.

$50M pool

Last verified: 1 Jun 2026Source: wellcomeleap.org